Observation
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Observation, covering 2021-05-18 to 2021-05-18. Get the full timeline:
Most recent: Clinical Trial Update: Lenalidomide or Observation in Treating Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma [Phase 3]